710 related articles for article (PubMed ID: 26209070)
21. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
22. Design of the interface of edible nanoemulsions to modulate the bioaccessibility of neuroprotective antioxidants.
Plaza-Oliver M; Baranda JF; Rodríguez Robledo V; Castro-Vázquez L; Gonzalez-Fuentes J; Marcos P; Lozano MV; Santander-Ortega MJ; Arroyo-Jimenez MM
Int J Pharm; 2015 Jul; 490(1-2):209-18. PubMed ID: 25997659
[TBL] [Abstract][Full Text] [Related]
23. Enhanced oral delivery of risperidone through a novel self-nanoemulsifying powder (SNEP) formulations: in-vitro and ex-vivo assessment.
Bandi S; Sanka K; Bakshi V
J Microencapsul; 2016 Sep; 33(6):544-553. PubMed ID: 27568868
[TBL] [Abstract][Full Text] [Related]
24. Development of risperidone liposomes for brain targeting through intranasal route.
Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY
Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571
[TBL] [Abstract][Full Text] [Related]
25. Efficiency of emulsifier-free emulsions and emulsions containing rapeseed lecithin as delivery systems for vectorization and release of coenzyme Q10: physico-chemical properties and in vitro evaluation.
Kaci M; Arab-Tehrany E; Dostert G; Desjardins I; Velot E; Desobry S
Colloids Surf B Biointerfaces; 2016 Nov; 147():142-150. PubMed ID: 27497933
[TBL] [Abstract][Full Text] [Related]
26. Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation.
Abdelbary G; Amin M; Salah S
Pharm Dev Technol; 2013; 18(6):1294-304. PubMed ID: 22468935
[TBL] [Abstract][Full Text] [Related]
27. Formation of vitamin D nanoemulsion-based delivery systems by spontaneous emulsification: factors affecting particle size and stability.
Guttoff M; Saberi AH; McClements DJ
Food Chem; 2015 Mar; 171():117-22. PubMed ID: 25308650
[TBL] [Abstract][Full Text] [Related]
28. High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions.
Kim JE; Park YJ
Colloids Surf B Biointerfaces; 2017 Feb; 150():362-372. PubMed ID: 27823852
[TBL] [Abstract][Full Text] [Related]
29. Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines.
Najlah M; Kadam A; Wan KW; Ahmed W; Taylor KM; Elhissi AM
Int J Pharm; 2016 Jun; 506(1-2):102-9. PubMed ID: 27107899
[TBL] [Abstract][Full Text] [Related]
30. Optimization and characterization of the formation of oil-in-water diazinon nanoemulsions: Modeling and influence of the oil phase, surfactant and sonication.
Badawy MEI; Saad ASA; Tayeb EHM; Mohammed SA; Abd-Elnabi AD
J Environ Sci Health B; 2017 Dec; 52(12):896-911. PubMed ID: 29111904
[TBL] [Abstract][Full Text] [Related]
31. Preparation of Nanoemulsions by Premix Membrane Emulsification: Which Parameters Have a Significant Influence on the Resulting Particle Size?
Gehrmann S; Bunjes H
J Pharm Sci; 2017 Aug; 106(8):2068-2076. PubMed ID: 28479362
[TBL] [Abstract][Full Text] [Related]
32. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
Kupetz E; Bunjes H
J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601
[TBL] [Abstract][Full Text] [Related]
33. Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review.
Hörmann K; Zimmer A
J Control Release; 2016 Feb; 223():85-98. PubMed ID: 26699427
[TBL] [Abstract][Full Text] [Related]
34. Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency.
Boche M; Pokharkar V
AAPS PharmSciTech; 2017 Apr; 18(3):686-696. PubMed ID: 27207184
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effects of eugenol nanoemulsion as a topical delivery system.
Esmaeili F; Rajabnejhad S; Partoazar AR; Mehr SE; Faridi-Majidi R; Sahebgharani M; Syedmoradi L; Rajabnejhad MR; Amani A
Pharm Dev Technol; 2016 Nov; 21(7):887-893. PubMed ID: 26365132
[TBL] [Abstract][Full Text] [Related]
36. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation.
Cheng Y; Liu M; Hu H; Liu D; Zhou S
AAPS PharmSciTech; 2016 Apr; 17(2):409-17. PubMed ID: 26195071
[TBL] [Abstract][Full Text] [Related]
37. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
Wang YJ; Wang J; Zhang HY; He HB; Tang X
J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
[TBL] [Abstract][Full Text] [Related]
38. Optimization of preparation conditions for quercetin nanoemulsions using response surface methodology.
Karadag A; Yang X; Ozcelik B; Huang Q
J Agric Food Chem; 2013 Mar; 61(9):2130-9. PubMed ID: 23330985
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization and bioavailability by oral administration of O/W curcumin nanoemulsions stabilized with lysophosphatidylcholine.
Chávez-Zamudio R; Ochoa-Flores AA; Soto-Rodríguez I; Garcia-Varela R; García HS
Food Funct; 2017 Sep; 8(9):3346-3354. PubMed ID: 28856361
[TBL] [Abstract][Full Text] [Related]
40. Nanocarrier-based topical drug delivery for an antifungal drug.
Hussain A; Samad A; Nazish I; Ahmed FJ
Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
